Si prevede che il mercato del trattamento del linfedema raggiungerà gli 11,58 miliardi di dollari entro il 2028 rispetto agli 8,15 miliardi di dollari del 2021; si prevede che crescerà a un CAGR del 5,1% dal 2021 al 2028.
Il linfedema è una condizione in cui il corpo si allarga in modo anomalo a causa della linfostasi causata dal sistema linfatico disfunzione. Colpisce più comunemente gli arti inferiori (90%), gli arti superiori (10%) e i genitali (1%). Il linfedema primario è presente alla nascita mentre il linfedema secondario è causato da inefficienza o danno del sistema linfatico. Il linfedema secondario si sviluppa frequentemente dopo il trattamento del cancro. Il linfedema è causato da ostruzioni nel passaggio del fluido linfatico causate da interventi chirurgici, radioterapia o crescita del cancro. Le sensazioni di oppressione o pesantezza; gonfiore alle gambe, alle braccia o ad altre parti del corpo; dolore o disagio; e la fibrosi, che ispessisce o indurisce la pelle, sono tra i sintomi più comuni del linfedema.
Approfondimenti strategici
La crescita del mercato del trattamento del linfedema è attribuita alla crescente incidenza del linfedema e al crescente numero di programmi di gestione del linfedema con un’impennata nella promozione dei servizi di telemedicina in vari paesi. Tuttavia, la mancanza di professionisti qualificati e gli elevati costi chirurgici nelle economie in via di sviluppo ostacolano la crescita del mercato.
Regioni redditizie nel mercato del trattamento del linfedema
< br />
Market Insights
Crescente casi di linfedema
Secondo il Dipartimento della salute e dei servizi umani degli Stati Uniti, il linfedema può si verificano nei malati di cancro all'inizio della malattia o dopo il suo trattamento, che influenzano il drenaggio linfonodale. Ad esempio, è stato riportato che può manifestarsi entro pochi giorni e fino a 30 anni dopo il trattamento del cancro al seno. Inoltre, l'80% dei pazienti manifesta l'esordio entro 3 anni dall'intervento chirurgico e il resto sviluppa edema con una percentuale dell'1% all'anno. Inoltre, un ampio gruppo di pazienti, in particolare donne, soffre di linfedema degli arti inferiori dopo il trattamento del cancro ginecologico, con la prevalenza più alta (37%) tra le sopravvissute al cancro vulvare e la prevalenza più bassa (7%) tra le sopravvissute al cancro ovarico. Inoltre, l’incidenza complessiva del linfedema del braccio varia dall’8% al 56% a due anni dall’intervento. Il sottostudio longitudinale Alliance Z 1071 dell'American College of Surgeons Oncology Group (ACOSOG) afferma che negli studi sul cancro al seno, i pazienti riportano un'incidenza cumulativa di 3 anni di gonfiore e pesantezza del braccio. Opzioni di trattamento del cancro altamente efficaci e avanzate aiutano a ridurre al minimo il rischio di linfedema. Pertanto, i principali attori nel mercato delle terapie antitumorali sono fortemente concentrati sul lancio di prodotti innovativi.
Approfondimenti basati sul tipo di condizione
In base al tipo di condizione, il mercato globale del trattamento del linfedema è stato segmentato in linfedema primario e linfedema secondario. Il segmento del linfedema secondario deteneva una quota maggiore del mercato nel 2021. Tuttavia, si prevede che il segmento del linfedema primario registrerà un CAGR più elevato nel mercato durante il periodo di previsione. L’attuale crescita del mercato del segmento del linfedema secondario è attribuita al fatto che il trattamento del cancro è una causa importante di linfedema secondario e la maggior parte delle persone che soffrono di linfedema secondario sono numerose nei paesi in via di sviluppo e in quelli sviluppati.
Mercato del trattamento del linfedema, per tipo di condizione: – 2021 e 2028
Tipo di trattamento - Approfondimenti basati
In base al tipo di trattamento, il Il mercato del trattamento del linfedema è stato segmentato in terapia laser, dispositivi di compressione e bendaggi, terapia farmacologica, procedure fisiologiche, procedure di debulking e altri. Il segmento delle procedure fisiologiche è ulteriormente segmentato in anastomosi linfovenosa (LVA) e trasferimento linfonodale vascolarizzato (VLNT). Inoltre, il segmento delle procedure di debulking è suddiviso in debulking chirurgico, liposuzione e altri. Il segmento dei dispositivi di compressione e dei bendaggi ha rappresentato la quota di mercato maggiore nel 2021. Le aziende nel mercato del trattamento del linfedema stanno sviluppando diversi tipi di indumenti compressivi e stanno promuovendo prodotti convenienti. Inoltre, si prevede che il segmento delle procedure fisiologiche registrerà il CAGR più elevato del mercato durante il periodo di previsione.
Approfondimenti basati sull'utente finale
In base all’utente finale, il mercato globale del trattamento del linfedema è stato segmentato in ospedali, cliniche, organizzazioni di ricerca clinica (CRO) e altri (centri di assistenza ambulatoriale e centri di assistenza primaria). Il segmento degli ospedali ha conquistato la quota di mercato maggiore nel 2021. Si prevede che il segmento delle cliniche registrerà il CAGR più elevato durante il periodo di previsione; la crescita del mercato di questo segmento può essere attribuita al fatto che i trattamenti per il linfedema sono offerti principalmente in centri o unità specializzate. Trattamenti chirurgici specializzati come la liposuzione e le procedure di debulking vengono eseguiti in cliniche specializzate che dispongono di un dipartimento dedicato alla neurologia o, più specificamente, al trattamento del linfedema.
Il lancio e le approvazioni dei prodotti sono in corso. strategie comunemente adottate dalle aziende nel mercato del trattamento del linfedema per espandere la propria presenza globale e i portafogli di prodotti. Inoltre, gli attori del mercato si concentrano sulla strategia di partnership per espandere la propria clientela, che, a sua volta, consente loro di mantenere il proprio marchio in tutto il mondo.
Profili aziendali
- < li>SISTEMI DI BIOCOMPRESSIONE
- Tactile Medical
- Smith & Nipote
- BSN medical GmbH
- Lohmann & Rauscher GmbH & Co. KG
- SIGVARIS GROUP
- ThermoTek
- Huntleigh Healthcare Limited
- 3M
- Mego Afek ltd
- li>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Lymphedema treatment mainly refers to the treatment options that are used in combatting primary and secondary lymphedema disease conditions. Some of the treatment types that are considered in the process include laser therapy, debulking procedures, liposuction, lymph node transfer, compression, and bandaging devices.
Key factors that are driving the growth of the market are increasing incidences of lymphedema and programs conducted by the government fuel the growth of the market.
The market is estimated to grow with a CAGR of 5.1% from 2021 to 2028.
BIOCOMPRESSION SYSTEMS; Tactile Medical; Smith and Nephew; BSN Medical GmbH; Lohmann & Rauscher GmbH & Co. KG; SIGVARIS GROUP; ThermoTek; Huntleigh Healthcare Limited; 3M; Mego Afek Ltd. are among the key companies operating in the lymphedema treatment market.
The List of Companies - Lymphedema Treatment Market
- Biocompression Systems
- Essity Medical Solutions
- L & R Group
- SIGVARIS
- Tactile Medical
- SMITH + NEPHEW
- Thermo Tek
- Huntleigh Healthcare Limited.
- Physiopedia
- AIROS Medical, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jan 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jan 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)